Windsor Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.83M Sell
14,216
-1,366
-9% -$160K 0.47% 42
2026
Q1
$1.87M Buy
15,582
+52
+0.3% +$6K 0.53% 38
2025
Q4
$1.63M Buy
15,530
+29
+0.2% +$2.72K 0.45% 40
2025
Q3
$1.3M Sell
15,501
-646
-4% -$53.2K 0.36% 44
2025
Q2
$1.28M Sell
16,147
-519
-3% -$41.3K 0.37% 45
2025
Q1
$1.5M Sell
16,666
-216
-1% -$20.2K 0.46% 40
2024
Q4
$1.68M Sell
16,882
-688
-4% -$70.9K 0.5% 39
2024
Q3
$2M Sell
17,570
-484
-3% -$57.5K 0.58% 35
2024
Q2
$2.24M Sell
18,054
-56
-0.3% -$7.21K 0.69% 32
2024
Q1
$2.39M Sell
18,110
-237
-1% -$29.2K 0.74% 31
2023
Q4
$2M Sell
18,347
-161
-0.9% -$16.7K 0.65% 32
2023
Q3
$1.91M Buy
18,508
+302
+2% +$32.5K 0.66% 32
2023
Q2
$2.1M Sell
18,206
-241
-1% -$27.4K 0.7% 30
2023
Q1
$1.96M Sell
18,447
-429
-2% -$46.3K 0.68% 31
2022
Q4
$2.09M Sell
18,876
-574
-3% -$58.7K 0.76% 29
2022
Q3
$1.68M Sell
19,450
-207
-1% -$18.5K 0.63% 33
2022
Q2
$1.79M Sell
19,657
-16
-0.1% -$1.42K 0.64% 32
2022
Q1
$1.61M Buy
19,673
+438
+2% +$34.5K 0.5% 39
2021
Q4
$1.47M Buy
19,235
+413
+2% +$32.9K 0.44% 43
2021
Q3
$1.41M Sell
18,822
-124
-0.7% -$9.43K 0.45% 42
2021
Q2
$1.47M Sell
18,946
-997
-5% -$74.2K 0.49% 39
2021
Q1
$1.47M Sell
19,943
-209
-1% -$15.4K 0.51% 39
2020
Q4
$1.57M Buy
20,152
+781
+4% +$59.7K 0.59% 39
2020
Q3
$1.53M Sell
19,371
-135
-0.7% -$10.6K 0.64% 36
2020
Q2
$1.44M Buy
19,506
+6,307
+48% +$475K 0.62% 36
2020
Q1
$969K Sell
13,199
-77
-0.6% -$6.05K 0.49% 43
2019
Q4
$1.15M Buy
13,276
+485
+4% +$39.8K 0.48% 48
2019
Q3
$1.03M Buy
12,791
+348
+3% +$27.9K 0.46% 55
2019
Q2
$995K Buy
12,443
+191
+2% +$14.6K 0.46% 55
2019
Q1
$972K Sell
12,252
-327
-3% -$24.5K 0.46% 55
2018
Q4
$917K Buy
12,579
+545
+5% +$38.5K 0.47% 54
2018
Q3
$814K Buy
12,034
+42
+0.4% +$2.68K 0.37% 66
2018
Q2
$694K Sell
11,992
-399
-3% -$22.5K 0.32% 71
2018
Q1
$644K Buy
12,391
+3,069
+33% +$166K 0.3% 71
2017
Q4
$500K Buy
9,322
+584
+7% +$32.4K 0.23% 84
2017
Q3
$534K Hold
8,738
0.27% 74
2017
Q2
$534K Buy
8,738
+339
+4% +$20.6K 0.27% 75
2017
Q1
$509K Sell
8,399
-735
-8% -$44.6K 0.26% 77
2016
Q4
$513K Buy
9,134
+384
+4% +$22.5K 0.28% 78
2016
Q3
$521K Buy
8,750
+376
+4% +$22K 0.29% 76
2016
Q2
$460K Buy
8,374
+673
+9% +$35.8K 0.27% 77
2016
Q1
$388K Buy
7,701
+260
+3% +$12.7K 0.24% 81
2015
Q4
$375K Sell
7,441
-98
-1% -$4.94K 0.23% 77
2015
Q3
$355K Sell
7,539
-498
-6% -$26.5K 0.21% 78
2015
Q2
$436K Buy
8,037
+1,128
+16% +$63.3K 0.25% 70
2015
Q1
$379K Buy
6,909
+1,300
+23% +$73.6K 0.22% 75
2014
Q4
$304K Buy
5,609
+46
+0.8% +$2.56K 0.17% 82
2014
Q3
$315K Sell
5,563
-2,069
-27% -$116K 0.18% 73
2014
Q2
$421K Buy
7,632
+455
+6% +$24.8K 0.24% 60
2014
Q1
$389K Buy
7,177
+448
+7% +$23.2K 0.23% 60
2013
Q4
$321K Buy
6,729
+1,400
+26% +$64K 0.19% 63
2013
Q3
$242K Buy
5,329
+565
+12% +$25.8K 0.14% 72
2013
Q2
$211K Buy
+4,764
New +$213K 0.13% 75

Other funds holding MRK

Windsor Capital Management's MRK Position: Q2 2026 in Review

Windsor Capital Management reduced its Merck (MRK) stake by 8.8% in Q2 2026, selling an estimated $160K and leaving 14,216 shares worth $1.83M. The position accounts for 0.47% of the portfolio, ranked #42.

Windsor Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.39M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Windsor Capital Management held 14,216 shares of Merck worth $1.83M as of Q2 2026.
  • Windsor Capital Management sold 1,366 Merck shares in Q2 2026, an estimated $160K.
  • Merck made up 0.47% of Windsor Capital Management's portfolio in Q2 2026, its #42 holding.
  • Windsor Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Windsor Capital Management's Merck position peaked at $2.39M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Windsor Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.